Download image:

Anthony Hickey

Distinguished Fellow, Aerosol and Nanomaterials Engineering

Anthony Hickey, Ph.D., Distinguished Fellow (appointed June 2012), is a senior research pharmacologist at RTI. Dr. Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development.

Since joining RTI in 2011, he has conducted research related to pulmonary drug and vaccine delivery for tuberculosis treatment and therapy. Additionally, Dr. Hickey is an adjunct professor of biomedical engineering at the University of North Carolina at Chapel Hill School of Medicine, emeritus professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, and founder and president of Cirrus Pharmaceuticals, Inc.

He has received many awards and honors and is an active member of several professional societies and committees, including the American Association for the Advancement of Science, American Association for Aerosol Research, and the Society of Toxicology. He is a fellow of the Society of Biology, the American Association of Pharmaceutical Scientists, and the American Association for the Advancement of Science.

Dr. Hickey holds 17 patents and has authored numerous books, book chapters, and more than 160 journal articles.


PhD, ScD, Pharmaceutical Sciences, University of Aston in Birmingham; MS, University of Birmingham, Toxicology; BS (with honors), Biology, Portsmouth Polytechnic.

Latest Publications

Hickey, A.J., Durham, P.G., Durham, P.G., Dharmadhikari, A., & Nardell, E.A. (2015). Inhaled drug treatment for tuberculosis: Past progress and future prospects. Journal of Controlled Release, Advance Online Publication .
Contreras, L.G., Sung, J., Ibrahim, M., Elbert, K., Edwards, D., & Hickey, A. (2015). Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs. Molecular Pharmaceutics, 12 (8):2642-2650.
Durham, P.G., Zhang, Y., German, N., Mortensen, N., Dhillon, J., Mitchison, D.A., Fourie, P.B., & Hickey, A.J. (2015). Spray dried aerosol particles of pyrazinoic acid salts for tuberculosis therapy. Molecular Pharmaceutics, 12 (8):2574-2581.
Achkar, J., Beverley, P., Boom, H., Evans, T., Hanekom, W., Hickey, A., et al. (2015). Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014, Vaccine, 33 (26):3038-3046.
Ziffels, S., Bemelmans, N.L., Durham, P.G., & Hickey, A.J. (2015). In vitro dry powder inhaler formulation performance considerations. Journal of Controlled Release, 199 :45-52.
View all publications by Anthony Hickey (231)


  • Pulmonary Biology
  • Aerosol Technology
  • Powder Dynamics
  • Pharmacokinetics and Drug Disposition